101 
FDA authorizes J&J's one-shot coronavirus vaccine
Bio Pharma Dive
FEBRUARY 27, 2021
The agency's emergency clearance makes J&J's vaccine the third available in the U.S., adding much-needed reinforcements at a critical time
2021
The true cost of COVID-19?
World of DTC Marketing
MARCH 4, 2021
SUMMARY: COVID-19 has killed many people worldwide, but how many really died from COVID, and how many died because they had an underlying chronic health problem as a major factor? We may never know, but we can not afford to do anything while our population becomes more obese and unhealthy.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Navigating the Global NHP Shortage: How to Keep Your Development Program on Track
Camargo
JANUARY 12, 2021
In the first half of 2020 and as a direct consequence of the ongoing pandemic, China issued a ban on the export of non-human primates (NHPs) , including those used for pharmaceutical research.
Climate impacts drive east-west divide in forest seed production
Scienmag
FEBRUARY 23, 2021
Western forests may be less able to regenerate following large-scale diebacks Credit: USGS DURHAM, N.C.
Johnson & Johnson Will Test its Vaccine in Infants
NY Times
FEBRUARY 28, 2021
The company’s coming trials will also involve pregnant women and people whose immune systems are compromised. internal-essential Children and Childhood Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Immune System Clinical Trials Vaccination and Immunization Babies and Infants Johnson & Johnson
Need Health Insurance? Marketplaces are Open Now!
Triage Cancer
FEBRUARY 22, 2021
Health Insurance Marketplaces are now open for a Special Enrollment Period (SEP). In the 36 states with Marketplaces on www.HealthCare.gov, individuals have the opportunity to buy a new health insurance policy or change policies until May 15, 2021.
Pfizer/BioNTech to trial COVID-19 vaccine in pregnant women and children
BioPharma Reporter
FEBRUARY 22, 2021
Pfizer and BioNTech have dosed the first participants in a Phase 2/3 study for their COVID-19 vaccine in pregnant women; and plan to trial the vaccine in children later this year. Bio Developments
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for pharmaceutical professionals from the widest variety of industry thought leaders.
More Trending
Disney characters will lend a hand to kids during MRI scans
Pharma Phorum
MARCH 4, 2021
Radiologists in Europe could soon have help keeping children calm as they have MRI scans from Disney favourites like Micky Mouse, Winnie the Pooh and the Little Mermaid.
Over-the-Counter Nasal Spray Could Be Effective Against COVID-19
BioSpace
JANUARY 25, 2021
An in vitro study conducted by scientists from Northwestern University and Utah State University concluded that components found within the Xlear nasal spray, particularly grapefruit seed extract and xylitol, were successful in statistically reducing the amount of SARS-CoV-2 in a patient
ERT Imaging Accelerates Ground-Breaking Research to Improve the Development of Oncology and CNS Treatments
ERT
MARCH 1, 2021
Blue Earth Diagnostics utilizing ERT imaging solution to evaluate a novel imaging agent for potential use to inform brain metastases disease management.
Bristol Myers finally wins FDA approval for cancer cell therapy
Bio Pharma Dive
FEBRUARY 5, 2021
Delays tied to factory inspections had pushed an FDA decision on Breyanzi past a key deadline, allowing Bristol Myers to avoid paying billions of dollars in payouts to investors
The health care industry should also invest more preventative health
World of DTC Marketing
FEBRUARY 24, 2021
SUMMARY: In a recent study by The Harris Poll on behalf of TIME, the overwhelming majority of Americans (78%) admitted to delaying routine medical services and health care appointments due to the coronavirus pandemic.
Neurology’s Growing Need for Disposable Technologies
Pharma Mirror
JANUARY 10, 2021
By Boris Goldstein, Co-Founder & Executive Chairman at Brain Scientific COVID-19 is known for its impacts on a patient’s respiratory system, but it has also been found to affect individuals in unique ways and with varying severity levels depending on their age, risk factors, and comorbidities.
How to harness artificial intelligence to boost business and make our world more human
Scienmag
JANUARY 4, 2021
Welcome to the World of Hyperautomation Credit: World Scientific Two centuries ago, the Industrial Revolution began to automate “blue-collar” work, allowing higher profits and wider societal improvements like the reduction of famine and the increase in living standards.
Pfizer Will Ship Fewer Covid-19 Vaccine Vials to Account for ‘Extra’ Doses
NY Times
JANUARY 22, 2021
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
FDA Says Data Does Not Support Changes to COVID-19 Vaccine Doses
XTalks
JANUARY 8, 2021
The US Food and Drug Administration (FDA) released a statement this week about dosing schedules for COVID-19 vaccines, saying that any dose changes would be premature.
WHO weighs in on COVID-19 vaccine second dose delay
BioPharma Reporter
JANUARY 7, 2021
The World Health Organizationâs vaccine advisory group recommends the two doses of the Pfizer/BioNTech vaccine should be delivered 21 to 28 days apart: although it adds that the maximum time period between doses could be up to six weeks in some situations. Markets & Regulations
Colorado RFP on Drug Importation Accounts for Canada’s Order Protecting Against Shortages
Pharmacy Checkers
JANUARY 27, 2021
This week, the Colorado Department of Health Care Policy and Financing issued a request for proposals, called an Invitation to Negotiate, to operate a state wholesale drug importation program as permitted under federal law and the administrative final rule issued by HHS last year, referred to as the Section 804 rule.
How accidental advocacy is amplifying the GM1 voice
Pharma Phorum
MARCH 3, 2021
Rare disease families need to stand up and be counted if they want things to change said mum and advocate Christine Waggoner. She spoke to pharmaphorum as part of our Patients Insights series. Like many “rare disease mums”, Christine is an accidental advocate.
COVID-19 Long-Hauler Therapy Space Beginning to Take Shape
BioSpace
FEBRUARY 8, 2021
While the space is just beginning to emerge, therapies for long-haul COVID-19 patients are still very much an unmet need
Boehringer Ingelheim announces partnership with Google
Pharma Times
JANUARY 11, 2021
Partnership will aim to research and implement quantum computing in pharma R&D
As COVID-19 becomes a business, vaccine makers confront thorny pricing questions
Bio Pharma Dive
FEBRUARY 9, 2021
Yearly vaccinations could be required after the pandemic ebbs. Will drugmakers change how they approach pricing their shots
As pharma abandons the antibiotic market patients are at risk
World of DTC Marketing
MARCH 3, 2021
SUMMARY: According to Pew Internet “Despite antibiotics’ vital role in cancer care, companies have abandoned their development in favor of more profitable drugs.
5 Trends That Will Shape Pharma Marketing in 2021
Pharma Marketing Network
JANUARY 6, 2021
Throughout the year 2020, pharma marketers were forced to explore new strategies in order to keep up with the many evolving trends. Pharma marketers have quickly learned how to adapt to these trends and are prepared to take on new opportunities in 2021.
Origami with DNA
Scienmag
FEBRUARY 1, 2021
A team at TU Wien was able to answer important questions about the immune system – with a trick reminiscent of paper folding. Credit: TU Wien T-cells are an important component of our immune system: with the receptors they carry on their surface, they can recognise highly specific antigens.
Alzheimer’s Drug Shows Promise in Small Trial
NY Times
JANUARY 11, 2021
Participants with the disease still declined, but much more slowly than those receiving a placebo, investigators say. Alzheimer's Disease Clinical Trials Drugs (Pharmaceuticals) Brain Eli Lilly and Company donanemab
Thrombocytopenia Drugs Market: What Newer Agents Are Expected To Enter The Market?
Delveinsight
JANUARY 22, 2021
The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market.
'Vaccines are working': UK unveils real-world data from vaccination campaign
BioPharma Reporter
FEBRUARY 23, 2021
Real-world data from England shows that the Pfizer/BioNTech vaccine offers 'clear protection from first dose' and may help interrupt transmission; while Scottish data shows the first doses of vaccines led to a substantial fall in hospital admissions. Bio Developments
State Drug Importation Bills Just Got More Personal in California
Pharmacy Checkers
FEBRUARY 12, 2021
With lies and deception, Big Pharma has used the threat posed by rogue websites and counterfeit drugs to push back against U.S. state legislation to gain access to lower drug prices in Canada.
A new approach to COVID-19 treatment
Pharma Phorum
JANUARY 15, 2021
While pharma has raced to develop COVID-19 vaccines, US-based company NeuroRx is taking a different approach to treating the virus.
University of Oregon Campus Could Be Cornerstone of New Biotech Hotspot
BioSpace
FEBRUARY 14, 2021
A new biotech hotspot could be on the horizon in Oregon thanks to a $500 million gift to the University of Oregon from Nike co-founder Phil Knight, an alumnus of the university
CRUK scientists develop drug that targets KRAS pathways
Pharma Times
JANUARY 4, 2021
KRAS mutations are found in several hard-to-treat cancers
Gene therapy for hemophilia: So close, yet so far away
Bio Pharma Dive
JANUARY 28, 2021
Significant setbacks for pace-setting programs from BioMarin and UniQure have renewed questions about gene therapy’s promise, and its safety
And just like that, the goodwill is gone
World of DTC Marketing
JANUARY 1, 2021
THOUGHT: The reports of “pharma goodwill” were premature.
Why Mask-Associated Dry Eye Won’t Necessarily Boost Restasis Sales
XTalks
MARCH 1, 2021
Dry eye disease may sound innocuous, but it’s a condition that affects between 25 and 35 percent of individuals in the US, and pandemic-related lifestyle changes may be pushing that percentage up.
Researchers find peptide that treats, prevents killer citrus disease
Scienmag
FEBRUARY 5, 2021
Treatment causes deadly bacterium to leak and die Credit: Hailing Jin/UCR New research affirms a unique peptide found in an Australian plant can destroy the No. 1 killer of citrus trees worldwide and help prevent infection.
One and Done: Why People Are Eager for Johnson & Johnson’s Vaccine
NY Times
MARCH 4, 2021
Johnson & Johnson’s one-shot vaccine is allowing states to rethink distribution, even as health officials and experts worry some will view it as inferior.
Let's personalize your content